Albuminuria after fetal pancreatic islet transplantation: A 10-year follow-up

Péter Vörös, Gyula Farkas, Zoltán Lengyel, Rózsa Dégi, L. Rosivall, László Kammerer

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Aim of the study. The prevention of diabetic nephropathy is as yet an unresolved issue. The aim of our study was to assess the effects of transplantation of long-term cultured and cryopreserved fetal pancreas islets on metabolic control and the development of diabetic nephropathy. Methods. Serum C-peptide, glucose, HbA(1c), insulin requirements, urinary albumin excretion rate, and blood pressure of 10 insulin-dependent diabetic patients after transplantation were compared with a group of 27 insulin-dependent diabetic controls on insulin therapy only during a 10-year follow-up. Results. In the first year after transplantation mean insulin requirement decreased from 53.6 ± 2.2 to 35.8 ± 1.2 units. C-peptide levels appeared (0.55 ± 0.08 ng/ml) and remained detectable throughout the follow-up. Blood glucose and HbA(1c) were significantly (P <0.05) lower than in the controls. Mean albumin excretion rates of the transplant and the control groups during the follow up were 18.8 ± 8.5 and 11.7 ± 2.0, 16.6 ± 6.6 and 14.0 ± 2.3, 15.0 ± 5.0 and 15.1 ± 2.7, 15.3 ± 7.5 and 20.4 ± 4.2, 19.8 ± 6,2 and 36.7 ± 11.1, 11.7 ± 3.6 and 51.3 ± 14.6, 14.1 ± 4.2 and 71.4 ± 23.1, 22.7 ± 8.6 and 42.0 ± 28.1, 18.0 ± 5.9 and 107.6 ± 35.6, 21.7 ± 11.0 and 101.5 ± 29.3 μg/min respectively. From the 6th year the difference between the two groups was significant (P <0.001). In the transplant group initial mean systolic and diastolic blood pressure values were 132.0 ± 3.3 and 81.5 ± 1.5 mmHg, in the controls 130.4 ± 3.4 and 79.6 ± 1.6 mmHg respectively. Significant changes (P <0.05) of blood pressure during the follow-up or differences between the two groups were not observed. Conclusions. We conclude that fetal islet transplantation is effective in achieving good long-term diabetes control and in the prevention of diabetic nephropathy.

Original languageEnglish
Pages (from-to)2899-2904
Number of pages6
JournalNephrology Dialysis Transplantation
Volume13
Issue number11
DOIs
Publication statusPublished - Nov 1998

Fingerprint

Islets of Langerhans Transplantation
Albuminuria
antineoplaston A10
Insulin
Diabetic Nephropathies
Blood Pressure
C-Peptide
Transplantation
Albumins
Transplants
Blood Glucose
Pancreas
Glucose
Control Groups
Serum

Keywords

  • Albuminuria
  • Diabetes control
  • Diabetes mellitus
  • Diabetic nephropathy
  • Fetal pancreas islet transplantation

ASJC Scopus subject areas

  • Nephrology
  • Transplantation

Cite this

Albuminuria after fetal pancreatic islet transplantation : A 10-year follow-up. / Vörös, Péter; Farkas, Gyula; Lengyel, Zoltán; Dégi, Rózsa; Rosivall, L.; Kammerer, László.

In: Nephrology Dialysis Transplantation, Vol. 13, No. 11, 11.1998, p. 2899-2904.

Research output: Contribution to journalArticle

Vörös, Péter ; Farkas, Gyula ; Lengyel, Zoltán ; Dégi, Rózsa ; Rosivall, L. ; Kammerer, László. / Albuminuria after fetal pancreatic islet transplantation : A 10-year follow-up. In: Nephrology Dialysis Transplantation. 1998 ; Vol. 13, No. 11. pp. 2899-2904.
@article{ac85b5e518484885826023145a276868,
title = "Albuminuria after fetal pancreatic islet transplantation: A 10-year follow-up",
abstract = "Aim of the study. The prevention of diabetic nephropathy is as yet an unresolved issue. The aim of our study was to assess the effects of transplantation of long-term cultured and cryopreserved fetal pancreas islets on metabolic control and the development of diabetic nephropathy. Methods. Serum C-peptide, glucose, HbA(1c), insulin requirements, urinary albumin excretion rate, and blood pressure of 10 insulin-dependent diabetic patients after transplantation were compared with a group of 27 insulin-dependent diabetic controls on insulin therapy only during a 10-year follow-up. Results. In the first year after transplantation mean insulin requirement decreased from 53.6 ± 2.2 to 35.8 ± 1.2 units. C-peptide levels appeared (0.55 ± 0.08 ng/ml) and remained detectable throughout the follow-up. Blood glucose and HbA(1c) were significantly (P <0.05) lower than in the controls. Mean albumin excretion rates of the transplant and the control groups during the follow up were 18.8 ± 8.5 and 11.7 ± 2.0, 16.6 ± 6.6 and 14.0 ± 2.3, 15.0 ± 5.0 and 15.1 ± 2.7, 15.3 ± 7.5 and 20.4 ± 4.2, 19.8 ± 6,2 and 36.7 ± 11.1, 11.7 ± 3.6 and 51.3 ± 14.6, 14.1 ± 4.2 and 71.4 ± 23.1, 22.7 ± 8.6 and 42.0 ± 28.1, 18.0 ± 5.9 and 107.6 ± 35.6, 21.7 ± 11.0 and 101.5 ± 29.3 μg/min respectively. From the 6th year the difference between the two groups was significant (P <0.001). In the transplant group initial mean systolic and diastolic blood pressure values were 132.0 ± 3.3 and 81.5 ± 1.5 mmHg, in the controls 130.4 ± 3.4 and 79.6 ± 1.6 mmHg respectively. Significant changes (P <0.05) of blood pressure during the follow-up or differences between the two groups were not observed. Conclusions. We conclude that fetal islet transplantation is effective in achieving good long-term diabetes control and in the prevention of diabetic nephropathy.",
keywords = "Albuminuria, Diabetes control, Diabetes mellitus, Diabetic nephropathy, Fetal pancreas islet transplantation",
author = "P{\'e}ter V{\"o}r{\"o}s and Gyula Farkas and Zolt{\'a}n Lengyel and R{\'o}zsa D{\'e}gi and L. Rosivall and L{\'a}szl{\'o} Kammerer",
year = "1998",
month = "11",
doi = "10.1093/ndt/13.11.2899",
language = "English",
volume = "13",
pages = "2899--2904",
journal = "Nephrology Dialysis Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - Albuminuria after fetal pancreatic islet transplantation

T2 - A 10-year follow-up

AU - Vörös, Péter

AU - Farkas, Gyula

AU - Lengyel, Zoltán

AU - Dégi, Rózsa

AU - Rosivall, L.

AU - Kammerer, László

PY - 1998/11

Y1 - 1998/11

N2 - Aim of the study. The prevention of diabetic nephropathy is as yet an unresolved issue. The aim of our study was to assess the effects of transplantation of long-term cultured and cryopreserved fetal pancreas islets on metabolic control and the development of diabetic nephropathy. Methods. Serum C-peptide, glucose, HbA(1c), insulin requirements, urinary albumin excretion rate, and blood pressure of 10 insulin-dependent diabetic patients after transplantation were compared with a group of 27 insulin-dependent diabetic controls on insulin therapy only during a 10-year follow-up. Results. In the first year after transplantation mean insulin requirement decreased from 53.6 ± 2.2 to 35.8 ± 1.2 units. C-peptide levels appeared (0.55 ± 0.08 ng/ml) and remained detectable throughout the follow-up. Blood glucose and HbA(1c) were significantly (P <0.05) lower than in the controls. Mean albumin excretion rates of the transplant and the control groups during the follow up were 18.8 ± 8.5 and 11.7 ± 2.0, 16.6 ± 6.6 and 14.0 ± 2.3, 15.0 ± 5.0 and 15.1 ± 2.7, 15.3 ± 7.5 and 20.4 ± 4.2, 19.8 ± 6,2 and 36.7 ± 11.1, 11.7 ± 3.6 and 51.3 ± 14.6, 14.1 ± 4.2 and 71.4 ± 23.1, 22.7 ± 8.6 and 42.0 ± 28.1, 18.0 ± 5.9 and 107.6 ± 35.6, 21.7 ± 11.0 and 101.5 ± 29.3 μg/min respectively. From the 6th year the difference between the two groups was significant (P <0.001). In the transplant group initial mean systolic and diastolic blood pressure values were 132.0 ± 3.3 and 81.5 ± 1.5 mmHg, in the controls 130.4 ± 3.4 and 79.6 ± 1.6 mmHg respectively. Significant changes (P <0.05) of blood pressure during the follow-up or differences between the two groups were not observed. Conclusions. We conclude that fetal islet transplantation is effective in achieving good long-term diabetes control and in the prevention of diabetic nephropathy.

AB - Aim of the study. The prevention of diabetic nephropathy is as yet an unresolved issue. The aim of our study was to assess the effects of transplantation of long-term cultured and cryopreserved fetal pancreas islets on metabolic control and the development of diabetic nephropathy. Methods. Serum C-peptide, glucose, HbA(1c), insulin requirements, urinary albumin excretion rate, and blood pressure of 10 insulin-dependent diabetic patients after transplantation were compared with a group of 27 insulin-dependent diabetic controls on insulin therapy only during a 10-year follow-up. Results. In the first year after transplantation mean insulin requirement decreased from 53.6 ± 2.2 to 35.8 ± 1.2 units. C-peptide levels appeared (0.55 ± 0.08 ng/ml) and remained detectable throughout the follow-up. Blood glucose and HbA(1c) were significantly (P <0.05) lower than in the controls. Mean albumin excretion rates of the transplant and the control groups during the follow up were 18.8 ± 8.5 and 11.7 ± 2.0, 16.6 ± 6.6 and 14.0 ± 2.3, 15.0 ± 5.0 and 15.1 ± 2.7, 15.3 ± 7.5 and 20.4 ± 4.2, 19.8 ± 6,2 and 36.7 ± 11.1, 11.7 ± 3.6 and 51.3 ± 14.6, 14.1 ± 4.2 and 71.4 ± 23.1, 22.7 ± 8.6 and 42.0 ± 28.1, 18.0 ± 5.9 and 107.6 ± 35.6, 21.7 ± 11.0 and 101.5 ± 29.3 μg/min respectively. From the 6th year the difference between the two groups was significant (P <0.001). In the transplant group initial mean systolic and diastolic blood pressure values were 132.0 ± 3.3 and 81.5 ± 1.5 mmHg, in the controls 130.4 ± 3.4 and 79.6 ± 1.6 mmHg respectively. Significant changes (P <0.05) of blood pressure during the follow-up or differences between the two groups were not observed. Conclusions. We conclude that fetal islet transplantation is effective in achieving good long-term diabetes control and in the prevention of diabetic nephropathy.

KW - Albuminuria

KW - Diabetes control

KW - Diabetes mellitus

KW - Diabetic nephropathy

KW - Fetal pancreas islet transplantation

UR - http://www.scopus.com/inward/record.url?scp=0031755786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031755786&partnerID=8YFLogxK

U2 - 10.1093/ndt/13.11.2899

DO - 10.1093/ndt/13.11.2899

M3 - Article

C2 - 9829498

AN - SCOPUS:0031755786

VL - 13

SP - 2899

EP - 2904

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

SN - 0931-0509

IS - 11

ER -